全民健康保險藥品給付規定 / 健保碼及健保價 |
See related Avelox[威洛速] information |
|
製造商 |
Bayer Schering Pharma |
代理/經銷商 |
Bayer Schering Pharma |
成份 |
Moxifloxacin HCl |
適應症 |
Treatment of adults ≥ 18 years with upper & lower respiratory tract infections such as acute sinusitis, acute exacerbation of chronic bronchitis, community acquired pneumonia; skin & soft tissue infections; complicated intra-abdominal infection. |
用量 |
1 tab/bot (400 mg) once daily. Duration: Acute exacerbation of chronic bronchitis 5 days. Community acquired pneumonia 10 days (IV 7-14 days). Acute sinusitis 7 days. Skin & soft tissue infection 7-21 days. Complicated intra-abdominal infection 5-14 days. |
用法 |
May be taken with or without food |
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
禁忌 |
Hypersensitivity. Children, growing adolescent. Pregnancy, lactation. |
注意事項 |
Seizures, patients with known or suspected CNS disorders which may predispose to seizures or lower the seizure threshold. Severe hepatic impairment. Patients with congenital or acquired syndromes of QTc prolongation or patients with concomitant medication known to prolong the QTc interval. |
不良反應 |
GI disturbances (eg nausea, vomiting, dyspepsia, abdominal pain); headache, dizziness; taste perversion; musculoskeletal effects (eg back pain, arthralgia); CVS effects (eg tachycardia, hypertension); hematological changes; CNS disturbances eg (insomnia, convulsion); skin reactions (eg rash, pruritus); visual disturbances.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
交互作用 |
Antacids, minerals & multivit.
View more drug interactions with Avelox[威洛速] |
本商品之市售規格 |
劑型 |
包裝 |
圖片 |
Avelox 膜衣錠 |
Avelox 400 mg x 5's |
 |
|
Avelox 輸注液 |
|
|
Manufacturer: |
Bayer Schering Pharma |
Distributor: |
Bayer Schering Pharma
|
|
|
|